On July 23, the FDA's Pharmacy Compounding Advisory Committee voted to recommend easing restrictions on four peptides that have gained a devoted following among athletes, longevity seekers, and patients with chronic inflammatory conditions
On April 15, 2026, the FDA announced the removal of BPC-157 from its 503A Category 2 list, effective April 22, 2026, because the original nominations were withdrawn
The cost of these supplements can vary widely depending on manufacturing standards, sourcing, branding, and whether companies invest in independent testing
Suggested use: As a dietary supplement, take 2 capsules daily, or as directed by a healthcare practitioner